metricas
covid
Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Do cerebral venous thrombosis risk factors influence the development of an assoc...
Journal Information
Vol. 26. Issue 1.
Pages 13-19 (January 2011)
Share
Share
Download PDF
More article options
Vol. 26. Issue 1.
Pages 13-19 (January 2011)
Original article
Full text access
Do cerebral venous thrombosis risk factors influence the development of an associated venous infarction?
¿Influyen los factores de riesgo de trombosis venosa cerebral en el desarrollo de infarto venoso asociado?
Visits
1363
I. Sanz Gallego, B. Fuentes, P. Martínez-Sánchez, E. Díez Tejedor
Corresponding author
ediezt@meditex.es

Corresponding author.
Servicio de Neurología, Centro de Ictus, Instituto de Investigación IdiPAZ, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain
This item has received
Article information
Abstract
Introduction

Cerebral venous thrombosis (CVT) is a multifactorial process with a wide clinical spectrum and many associated risk factors (RF) that could be complicated with venous infarction (VI). We study the infl uence of RF in the developing of venous infarction in patients with CVT.

Patients and methods

An observational study with consecutive inclusion of patients with CVT diagnosis admitted to the Stroke Unit of a Neurology Department between 1995 and 2007. RF were identifi ed and their distribution according to the presence of VI was analysed.

Results

A total of 52 patients were included (37 female; 71.15%) with mean age of 46.73 years (range 18–78 years). The most frequent RF associated with CVT were thrombophilia (26.92%) and oral contraceptives (OC) (25% of all the patients and in 35.13% of females). The most frequent RF in patients with venous infarction was thrombophilia (40.9%), whilst in the CVT group without venous infarction the use of oral contraceptives predominated (26.7% of the total sample; 38% of females), with thrombophilic states only being detected in 16.5%. No cases of venous infarction were found in the group of patients with oral contraceptives but without an associated thrombophilic state.

Conclusion

There appears to be a different profi le of associated RF in patients with venous infarction associated to CVT, with the presence of thrombophilia prevailing.

Keywords:
Venous infarction
Cerebral venous thrombosis
Risk factors
Thrombophilia
Oral contraceptives
Resumen
Introducción

La trombosis venosa cerebral (TVC) es un proceso multifactorial con amplio espectro clínico y de factores de riesgo (FR), que puede presentar o no infarto venoso. Estudiamos los FR que infl uyen en el desarrollo del infarto venoso en pacientes con diagnóstico de TVC.

Pacientes y métodos

Estudio observacional con inclusión de pacientes consecutivos con diagnóstico de TVC atendidos por la Unidad de Ictus del servicio de Neurología entre los años 1995 y 2007. Se identifi can los FR y se analiza su distribución en función de la presencia del infarto venoso.

Resultados

Se incluyeron 52 pacientes (37 mujeres; 71,15%) con edad media de 46,73 años (18-78 años). Los factores de riesgo de TVC más frecuentes fueron los estados de hipercoagulabilidad hereditarios (26,92%) y el uso de anticonceptivos orales (ACO) (25% del total muestral y 35,13% de las mujeres). Entre los FR identifi cados en pacientes con infarto venoso predominan los trastornos de hipercoagulabilidad hereditarios (40,9%) mientras que en los casos sin infarto venoso, el factor más frecuente es el uso de ACO (26,7%; 38% de las mujeres), estando presentes los estados de hipercoagulabilidad sólo en el 16,5%. No observamos ningún caso de infarto venoso con tratamiento ACO y sin estado de hipercoagulabilidad asociado.

Conclusiones

En los pacientes con infarto venoso asociado a TVC parece existir un diferente perfi l de factores de riesgo asociado, predominando la presencia de estados protrombóticos hereditarios.

Palabras clave:
Infarto venoso
Trombosis venosa cerebral
Factores de riesgo
Trombofilia
Anticonceptivos orales
Full text is only aviable in PDF
References
[1.]
M.G. Bousser, J.M. Ferro.
Cerebral venous thrombosis: an update.
Lancet Neurol, 6 (2007), pp. 162-170
[2.]
H. Allroggen, R.J. Abbott.
Cerebral venous sinus thrombosis.
Postgrad Med J, 76 (2000), pp. 12-15
[3.]
J.M. Ferro, P. Canhão, J. Stam, M.G. Bousser, F. Barinagarrementeria, ISCVT Investigators.
Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).
[4.]
G.R. de Freitas, J. Bogousslavsky.
Risk factors of cerebral vein and sinus thrombosis.
Front Neurol Neurosci, 23 (2008), pp. 23-54
[5.]
M. Sheerani, M.Z. Urfy.
Oral contraceptives and cerebral venous thrombosis: case report and a brief review of literature.
J Pak Med Assoc, 56 (2006), pp. 559-561
[6.]
M. Saadatnia, F. Fatehi, K. Basiri, S.A. Mousavi, G.K. Mehr.
Cerebral venous sinus thrombosis risk factors.
Int J Stroke, 4 (2009), pp. 111-123
[7.]
Z.K. Otrock, A.T. Taher, W.A. Shamseddeen, R.A. Mahfouz.
Thrombophilic risk factors among 16 Lebanese patients with cerebral venous and sinus thrombosis.
J Thromb Thrombolysis, 26 (2008), pp. 41-43
[8.]
S.F. de Brujin, J. Stam, M.M. Koopman, J.P. Vanderbroucke.
Casecontrol study of risk of cerebral sinus thrombosis in oral contraceptives users and in (correction of who are) carriers of hereditary prothrombotic conditions. The cerebral sinus thrombosis study group.
BMJ, 316 (1998), pp. 589-592
[9.]
I. Martinelli, T. Bataglioli, P. Pedrotti, M. Cattaneo, P.M. Manucci.
Hyperhomocysteinemia in cerebral vein thrombosis.
Blood, 102 (2003), pp. 1363-1366
[10.]
I. Martinelli, E. Sacchi, G. Landi, E. Taioli, F. Duca, P.M. Mannucci.
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
N Eng J Med, 338 (1998), pp. 1793-1797
[11.]
Díez-Tejedor en nombre del Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología. Guía para el diagnostico y tratamiento del ictus. España: Sociedad Española de Neurología; 2006.
[12.]
S. Appenzeller, C.B. Zeller, J.M. Annichino-Bizzachi, L.T. Costallat, L. Deus-Silva, B. Voetsch, et al.
Cerebral venous thrombosis: infl uence of risk factors and imaging fi ndings on prognosis.
Clin Neurol Neurosurg, 107 (2005), pp. 371-378
[13.]
T. Gadelha, C. André, A.A. Jucá, M. Nucci.
Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis.
Cerebrovasc Dis, 19 (2005), pp. 49-52
[14.]
G. Sébire, B. Tabarki, D.E. Saunders, I. Leroy, R. Liesner, C. Saint-Martin, et al.
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome.
Brain, 128 (2005), pp. 477-489
[15.]
E. Stolz, B. Kemkes-Matthes, B. Pötzsch, M. Hahn, J. Kraus, A. Wirbartz, et al.
Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis.
Acta Neurol Scand, 102 (2000), pp. 31-36
[16.]
C.E. Hillier, P.W. Collins, D.J. Bowen, S. Bowley, C.M. Wiles.
Inherited prothrombotic risk factors and cerebral venous thrombosis.
QJM, 91 (1998), pp. 677-680
[17.]
A. González-Hernández, O. Fabre-Pi, J.C. López-Fernández, V. Araña-Toledo, C. López-Veloso, J. Suárez-Muñoz.
The prevalence of clotting disorders in a series of cases of thrombosis of the cerebral venous sinuses.
Rev Neurol, 45 (2007), pp. 661-664
[18.]
J.M. Flores Barragan, A. Hernández González, M.J. Gallardo Alcañiz, M.A. del Real Francia, J. Vaamonde Gamo.
Clinicalf and therapeutic heterogeneity of cerebral venous thrombosis: a description of a series of 20 cases.
Rev Neurol, 49 (2009), pp. 573-576
[19.]
A. Alonso Cánovas, J. Masjuan, J. González Valcárcel, M.C. Matute Lozano, J. García Caldentey, M.A. Alonso Arias, et al.
Cerebral venous thrombosis: when etiology makes the difference.
Neurologia, 24 (2009), pp. 439-445
[20.]
F. Dentali, M. Gianni, M.A. Crowther, W. Ageno.
Natural history of cerebral vein thrombosis: a systematic review.
Blood, 108 (2006), pp. 1129-1134
[21.]
P. Canhão, J.M. Ferro, A.G. Lindgren, M.G. Bousser, J. Stam, F. Barinagarrementeria, ISCVT Investigators.
Causes and predictors of death in cerebral venous thrombosis.
Copyright © 2011. Sociedad Española de Neurología
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos